SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '2eyy'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1BDW_B_DVAB8_0
(GRAMICIDIN A)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
3 / 3 VAL A  37
VAL A  51
TRP A  15
None
0.95A 1bdwA-2eyyA:
undetectable
1bdwB-2eyyA:
undetectable
1bdwA-2eyyA:
4.41
1bdwB-2eyyA:
4.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KVV_A_URFA254_1
(URIDINE
PHOSPHORYLASE)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 6 GLY A 126
GLN A 123
ILE A 128
VAL A 127
None
1.05A 3kvvA-2eyyA:
undetectable
3kvvA-2eyyA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KVV_B_URFB254_1
(URIDINE
PHOSPHORYLASE)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 6 GLY A 126
GLN A 123
ILE A 128
VAL A 127
None
1.05A 3kvvB-2eyyA:
undetectable
3kvvB-2eyyA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KVV_C_URFC254_1
(URIDINE
PHOSPHORYLASE)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 6 GLY A 126
GLN A 123
ILE A 128
VAL A 127
None
1.03A 3kvvC-2eyyA:
undetectable
3kvvC-2eyyA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KVV_D_URFD254_1
(URIDINE
PHOSPHORYLASE)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 6 GLY A 126
GLN A 123
ILE A 128
VAL A 127
None
1.02A 3kvvD-2eyyA:
undetectable
3kvvD-2eyyA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KVV_E_URFE254_1
(URIDINE
PHOSPHORYLASE)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 6 GLY A 126
GLN A 123
ILE A 128
VAL A 127
None
1.07A 3kvvE-2eyyA:
undetectable
3kvvE-2eyyA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3KVV_F_URFF254_1
(URIDINE
PHOSPHORYLASE)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 6 GLY A 126
GLN A 123
ILE A 128
VAL A 127
None
1.04A 3kvvF-2eyyA:
undetectable
3kvvF-2eyyA:
20.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E1V_B_URFB1301_1
(URIDINE
PHOSPHORYLASE)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 7 GLY A 126
GLN A 123
ILE A 128
VAL A 127
None
1.05A 4e1vB-2eyyA:
undetectable
4e1vB-2eyyA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4E1V_F_URFF1301_1
(URIDINE
PHOSPHORYLASE)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 6 GLY A 126
GLN A 123
ILE A 128
VAL A 127
None
1.07A 4e1vF-2eyyA:
undetectable
4e1vF-2eyyA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_A_OBNA1104_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 5 PRO A 165
ASP A 163
ASN A 171
ILE A 182
None
1.42A 4hytA-2eyyA:
undetectable
4hytA-2eyyA:
11.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4HYT_C_OBNC2004_2
(SODIUM/POTASSIUM-TRA
NSPORTING ATPASE
SUBUNIT ALPHA-1)
2eyy V-CRK SARCOMA VIRUS
CT10 ONCOGENE
HOMOLOG ISOFORM A

(Homo
sapiens)
4 / 4 PRO A 165
ASP A 163
ASN A 171
ILE A 182
None
1.42A 4hytC-2eyyA:
0.0
4hytC-2eyyA:
11.54